Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mederos Alfonso N"'
Autor:
Imbimbo, M., Ghisoni, E., Mulvey, A., Bouchaab, H., Mederos Alfonso, N., Karp, D., Camidge, D.R., Mansfield, A.S., Yim, C.Y., Ames, T.D., Price, M., Baeck, J., O'Donnell, J.F., Peters, S.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Obeid, M., Petit, P-F., Latifyan, S., Daoudlarian, D., Joo, V., Bartolini, R., Bouchaab, H., Mederos Alfonso, N., Abdelhamid, K., Doms, J., Ferahta, N., Mencarelli, L., Stravodimou, A., Shabafrouz, K., Pantaleo, G., Peters, S.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S699-S700
Autor:
Lopes, A. M. D. S., Colomer-Lahiguera, S., Mederos-Alfonso, N-N., Lopez, V. Aedo, Spurrier-Bernard, G., Tolstrup, L. K., Pappot, H., Aspeslagh, S., Rogiers, A., Neyns, B., Haanen, J. B. A. G., Mitchell, S. A., Addeo, A., Michielin, O. A., Eicher, M.
Publikováno v:
Lopes, A M D S, Colomer-Lahiguera, S, Mederos-Alfonso, N-N, Lopez, V A, Spurrier-Bernard, G, Tolstrup, L K, Pappot, H, Aspeslagh, S, Rogiers, A, Neyns, B, Haanen, J B A G, Mitchell, S A, Addeo, A, Michielin, O A & Eicher, M 2021, ' Selecting patient-reported outcomes to monitor symptomatic toxicities of immune-checkpoint inhibitors: A Delphi study ', Annals of Oncology, vol. 32, no. Suppl. 5, 1686P, pp. S1180 . https://doi.org/10.1016/j.annonc.2021.08.1658
Background: Immune-related Adverse Events (IrAEs) present a new challenge to patient safety. The use of Patient-Reported Outcomes (PROs) to monitor adverse events is increasing. Existing measures like the PRO version of the Common Terminology Criteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a2408daf0ee6f14687c93c1fc0ed3542
https://biblio.vub.ac.be/vubir/selecting-patientreported-outcomes-to-monitor-symptomatic-toxicities-of-immunecheckpoint-inhibitors-a-delphi-study(b99b8fb7-4dce-4f0f-b368-3597a72fa2c3).html
https://biblio.vub.ac.be/vubir/selecting-patientreported-outcomes-to-monitor-symptomatic-toxicities-of-immunecheckpoint-inhibitors-a-delphi-study(b99b8fb7-4dce-4f0f-b368-3597a72fa2c3).html
Autor:
Jörger, M., García San Andrés, B., Joerger, M., Mederos-Alfonso, N-N., Metaxas, Y., Brock, E.
Publikováno v:
In Annals of Oncology April 2022 33 Supplement 2:S102-S102
Autor:
Lopes, A.M.D.S., Colomer-Lahiguera, S., Mederos-Alfonso, N-N., Lopez, V. Aedo, Spurrier-Bernard, G., Tolstrup, L.K., Pappot, H., Aspeslagh, S., Rogiers, A., Neyns, B., Haanen, J.B.A.G., Mitchell, S.A., Addeo, A., Michielin, O.A., Eicher, M.
Publikováno v:
In Annals of Oncology September 2021 32 Supplement 5:S1180-S1180
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ghisoni E; Department of Oncology, Lausanne University Hospital, Switzerland; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Wicky A; Department of Oncology, Lausanne University Hospital, Switzerland., Bouchaab H; Department of Oncology, Lausanne University Hospital, Switzerland., Imbimbo M; Department of Oncology, Lausanne University Hospital, Switzerland., Delyon J; Department of Oncology, Lausanne University Hospital, Switzerland., Gautron Moura B; Department of Oncology, Lausanne University Hospital, Switzerland., Gérard CL; Department of Oncology, Lausanne University Hospital, Switzerland., Latifyan S; Department of Oncology, Lausanne University Hospital, Switzerland., Özdemir BC; Department of Oncology, Lausanne University Hospital, Switzerland., Caikovski M; Department of Oncology, Lausanne University Hospital, Switzerland., Pradervand S; Department of Oncology, Lausanne University Hospital, Switzerland., Tavazzi E; Department of Information Engineering, University of Padova, Italy., Gatta R; Department of Oncology, Lausanne University Hospital, Switzerland., Marandino L; Department of Oncology, University of Torino, Italy., Valabrega G; Department of Oncology, University of Torino, Italy; Candiolo Cancer Institute, FPO, IRCCS, Candiolo (TO), Italy., Aglietta M; Department of Oncology, University of Torino, Italy; Candiolo Cancer Institute, FPO, IRCCS, Candiolo (TO), Italy., Obeid M; Service Immunologie et Allergie, Lausanne University Hospital, Switzerland., Homicsko K; Department of Oncology, Lausanne University Hospital, Switzerland; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Mederos Alfonso NN; Department of Oncology, Lausanne University Hospital, Switzerland., Zimmermann S; Department of Oncology, Lausanne University Hospital, Switzerland., Coukos G; Department of Oncology, Lausanne University Hospital, Switzerland; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Peters S; Department of Oncology, Lausanne University Hospital, Switzerland., Cuendet MA; Department of Oncology, Lausanne University Hospital, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA., Di Maio M; Department of Oncology, University of Torino, Italy; Medical Oncology, A.O. Ordine Mauriziano, Torino, Italy., Michielin O; Department of Oncology, Lausanne University Hospital, Switzerland; Ludwig Institute for Cancer Research, Lausanne, Switzerland. Electronic address: olivier.michielin@chuv.ch.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 May; Vol. 149, pp. 153-164. Date of Electronic Publication: 2021 Apr 14.